OSE Immunotherapeutics Announces the Appointment of Dominique Costantini as Interim CEO Following the Departure of Alexis Peyroles

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Italy ,France ,Italian ,Alexis Peyroles ,Dominique Costantini ,Nantes University Hospital ,Linkedin ,Twitter ,Boehringer Ingelheim ,Chief Executive ,Chief Executive Officer ,Laurence De Schoulepnikoff ,Chief Business Officer ,Chief Operating Officer ,Non Small Cell Lung Cancer ,Expansion Phase ,Universal Registration Document ,Coronavirus Pandemic ,Health ,Business ,Ose Immunotherapeutics Sa ,Europe ,Globe Newswire ,